References
  1. Short KR, Blackett PR, Gardner AW, Copeland KC. Vascular health in children and adolescents: effects of obesity and diabetes. Vasc Health Risk Manag . 2009;5:973-990. doi:10.2147/vhrm.s7116
  2. Min SK, Cho S, Kim HY, Kim SJ. Pediatric Vascular Surgery Review with a 30-Year-Experience in a Tertiary Referral Center. Vasc Specialist Int . 2017;33(2):47-54. doi:10.5758/vsi.2017.33.2.47
  3. Villegas L, Cahill AM, Meyers K. Pediatric Renovascular Hypertension: Manifestations and Management. Indian Pediatr . 2020;57(5):443-451.
  4. Baradhi KM, Bream P. Fibromuscular Dysplasia. [Updated 2020 Jul 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493204/
  5. Onen F, Akkoc N. Epidemiology of Takayasu arteritis. Presse Med . 2017;46(7-8 Pt 2):e197-e203. doi:10.1016/j.lpm.2017.05.034
  6. Rana MN, Al-Kindi SG. Prevalence and manifestations of diagnosed fibromuscular dysplasia by sex and race: Analysis of >4500 FMD cases in the United States. Heart Lung . 2021;50(1):168-173. doi:10.1016/j.hrtlng.2020.09.022
  7. St Peter SD, Ostlie DJ. A review of vascular surgery in the pediatric population. Pediatr Surg Int . 2007; 23(1): 1–10.
  8. Harry Goldblatt, James Lynch, Ramon F. Hanzal, Ward W. Summerville; STUDIES ON EXPERIMENTAL HYPERTENSION: I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA. J Exp Med  1 March 1934; 59 (3): 347–379. doi: https://doi.org/10.1084/jem.59.3.347
  9. Nair R, Vaqar S. Renovascular Hypertension. [Updated 2020 Dec 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551587/
  10. Patel, P.A., Cahill, A.M. Renovascular hypertension in children. CVIR Endovasc  4, 10 (2021). https://doi.org/10.1186/s42155-020-00176-5
  11. A.B. Weder, Evolution and hypertension. Hypertension, 49 (2007), pp. 260-265
  12. Nguyen TT, Adair LS, Suchindran CM, He K, Popkin BM. The association between body mass index and hypertension is different between East and Southeast Asians. Am J Clin Nutr . 2009;89(6):1905-1912. doi:10.3945/ajcn.2008.26809
  13. Olin JW, Gornik HL, Bacharach JM, Biller J, Fine L, Gray B, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation . 2014;129(9):1048-1078. doi:10.1161/01.cir.0000442577.96802.8c
  14. Bofinger A, Hawley C, Fisher P, Daunt N, Stowasser M, Gordon R. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J Hum Hypertens . 2001;15(3):185-190. doi:10.1038/sj.jhh.1001144
  15. Bloem LJ, Manatunga AK, Pratt JH. Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension . 1996;27(1):62-66. doi:10.1161/01.hyp.27.1.62
  16. Cornelissen VA, Fagard RH. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension . 2005;46(4):667-675. doi:10.1161/01.HYP.0000184225.05629.51
  17. Kelley GA, Kelley KA, Tran ZV. Aerobic exercise and resting blood pressure: a meta-analytic review of randomized, controlled trials. Prev Cardiol. 2001;4: 73–8
  18. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized controlled trials. Ann Intern Med. 2002; 136: 493–503.
  19. Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer D, et al. Elite endurance athletes and the ACE I allele–the role of genes in athletic performance. Hum Genet . 1998;103(1):48-50. doi:10.1007/s004390050781
  20. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, et al. Human gene for physical performance. Nature  393: 221–222, 1998. doi:10.1038/30374.
  21. Nazarov IB, Woods DR, Montgomery HE, Shneider OV, Kazakov VI, Tomilin NV, et al. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet  9: 797–801, 2001. doi:10.1038/sj.ejhg.5200711.
  22. Ruxton GD, Wilkinson DM. Endurance running and its relevance to scavenging by early hominins. Evolution. 2013 Mar;67(3):861-7. doi: 10.1111/j.1558-5646.2012.01815.x. Epub 2012 Oct 25. PMID: 23461334.
  23. Lee YH, Choi SJ, Ji JD, Song GG. Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to vasculitis: a meta-analysis. J Renin Angiotensin Aldosterone Syst . 2012;13(1):196-201. doi:10.1177/1470320311434240
  24. Kumagai H, Tobina T, Ichinoseki-Sekine N, Ryo K, Tsuzaki T, Zempo H, et al. Role of selected polymorphisms in determining muscle fiber composition in Japanese men and women. J Appl Physiol (1985) . 2018;124(5):1377-1384. doi:10.1152/japplphysiol.00953.2017
  25. Tobina T, Michishita R, Yamasawa F, Zhang B, Sasaki H, Tanaka H, et al. Association between the angiotensin I-converting enzyme gene insertion/deletion polymorphism and endurance running speed in Japanese runners. J Physiol Sci  60: 325–330, 2010. doi:10.1007/s12576-010-0100-4
  26. Wang G, Mikami E, Chiu LL, DE Perini A, Deason M, Fuku N, et al.Med Sci Sports Exerc  45: 892–900, 2013. doi:10.1249/MSS.0b013e31827c501f.
  27. Russo RAG, Katsicas MM. Takayasu Arteritis. Front Pediatr . 2018;6:265. Published 2018 Sep 24. doi:10.3389/fped.2018.00265